Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$581K Buy
4,819
+95
+2% +$10.4K 0.01% 1442
2026
Q1
$392K Sell
4,724
-593
-11% -$50.8K ﹤0.01% 1583
2025
Q4
$455K Sell
5,317
-127
-2% -$10.6K 0.01% 1506
2025
Q3
$455K Buy
+5,444
New +$497K 0.01% 1477
2025
Q1
– Sell
-3,386
Closed -$371K – 1911
2024
Q4
$371K Buy
3,386
+1,399
+70% +$163K ﹤0.01% 1473
2024
Q3
$288K Sell
1,987
-311
-14% -$42.4K ﹤0.01% 1637
2024
Q2
$335K Buy
+2,298
New +$322K ﹤0.01% 1522

Other funds holding CROX

Atria Investments's CROX Position: Q2 2026 in Review

Atria Investments increased its Crocs (CROX) stake by 2% in Q2 2026, buying an estimated $10.4K and bringing the position to 4,819 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #1442.

Atria Investments first reported a position in CROX in Q2 2024 and has held it in 7 quarters since. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Atria Investments held 4,819 shares of Crocs worth $581K as of Q2 2026.
  • Atria Investments bought 95 Crocs shares in Q2 2026, an estimated $10.4K.
  • Crocs made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1442 holding.
  • Atria Investments first reported a position in Crocs in Q2 2024 and has held it in 7 quarters since.
  • 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.